ABSTRACT
As principais desordens alimentares são a anorexia nervosa e a bulimia nervosa. Qualquer indivíduo pode desenvolver estas desordens alimentares, porém, aproximadamente 85% destas desordens originam-se na adolescência. Alguns fatores sociais, como a pressão sobre a mulher em manter um suposto peso ideal e a diminuição ou impossibilidade de praticar regularmente atividades físicas, podem contribuir para a ocorrência destas desordens. Nos últimos anos temos observado um aumento na ocorrência destes distúrbios, principalmente entre pacientes do sexo feminino. Desta forma, esta revisão de literatura tem como objetivo mostrar aos profissionais de Odontologia, como se faz o diagnóstico destas desordens, quais são as principais características bucais dos pacientes que apresentam a bulimia ou anorexia nervosa, e as formas de tratamento que podem ser oferecidos a estes pacientes. O cirurgião-dentista tem um papel muito importante na identificação das desordens alimentares, pois através da anamnese e exame físico extra e intra-oral é possível descobrir sinais e sintomas sugestivos destas desordens e, desta forma, indicar um tratamento precoce.
Objetivo The main eating disorders are anorexia nervosa and bulimia nervosa. Anyone may develop them; about 85% of these disorders have the beginning during the adolescent time. Some factors as social pressure on women to maintain the ideal weight and the reduction of physic activity may contribute to the occurrence of such disorders. In the last years we have observed an increase in the occurrence of these disturbances, mainly among female patients. So, this literature review is aimed to show to Dentistry professionals how to diagnostic these disorders, how are the main oral characteristics of patients whose present bulimia or anorexia nervosa and the kinds of treatment that could be offered to the patients. The dental surgeon plays an important role on the identification of these food disorders, because by the anamnesis and physical exam in and out the mouth is possible to detect signs and symptoms that suggest these disorders, and then indicate an earlier treatment.
ABSTRACT
OBJECTIVE: The aim of the present study was to determine the in vitro maximum inhibitory dilution (MID) of two chlorhexidinebased oral mouthwashes (CHX): Noplak®, Periogard®, and one polyhexamethylene biguanide-based mouthwash (PHMB): Sanifill Premium® against 28 field Staphylococcus aureus strains using the agar dilution method. MATERIALS AND METHODS: For each product, decimal dilutions ranging from 1/10 to 1/655,360 were prepared in distilled water and added to Mueller Hinton Agar culture medium. After homogenization, the culture medium was poured onto Petri dishes. Strains were inoculated using a Steers multipoint inoculator and dishes were incubated at 37ºC for 24hours. For reading, MID was considered as the maximum dilution of the mouthwash still capable of inhibiting microbial growth. RESULTS: Sanifill Premium® inhibited the growth of all strains at 1/40 dilution and of 1 strain at 1/80 dilution. Noplak® inhibited the growth of 23 strains at 1/640 dilution and of all 28 strains at 1/320 dilution. Periogard® showed inhibited growth of 7 strains at 1/640 dilution and of all 28 strains at 1/320 dilution. Data were submitted to Kruskal-Wallis statistical test, showing significant differences between the mouthwashes evaluated (p<0.05). No significant difference was found between Noplak® and Periogard® (p>0.05). Sanifill Premium® was the least effective (p<0.05). CONCLUSION: It was concluded that CHX-based mouthwashes present better antimicrobial activity against S. Aureus than the PHMB-based mouthwash.
Subject(s)
Anti-Infective Agents, Local/administration & dosage , Biguanides/administration & dosage , Chlorhexidine/analogs & derivatives , Mouthwashes/administration & dosage , Staphylococcus aureus/drug effects , Colony Count, Microbial , Chlorhexidine/administration & dosage , Dose-Response Relationship, Drug , Dental Disinfectants/administration & dosage , Microbial Sensitivity Tests , Saliva/microbiologyABSTRACT
The maximum inhibitory dilution (MID) of triclosan-based mouthwashes against 28 Staphylococcus aureus strains was evaluated. Dilutions ranging from 1/10 to 1/655,360 were prepared. Strains were inoculated using a Steers multipoint inoculator. The MID was considered as the maximum dilution capable of inhibiting microorganism growth. The mouthwashes presented different MIDs.
A Diluição Inibitória Máxima (DIM) de anti-sépticos bucais à base de triclosan contra 28 cepas de Staphylococcus aureus foi avaliada. Diluições de 1/10 a 1/655.360 foram preparadas. As cepas foram inoculadas com inoculador multipontual Steers. A DIM foi a maior diluição do anti-séptico que inibiu crescimento microbiano. Os anti-sépticos apresentaram diferentes DIMs.
Subject(s)
Anti-Bacterial Agents , Bacterial Growth , Mouthwashes , Saliva , Staphylococcus aureus/growth & development , Staphylococcus aureus/isolation & purification , Triclosan , Methods , MethodsABSTRACT
The aim of this in vitro study was to determine the maximum inhibitory dilution (MID) of four cetylpyridinium chloride (CPC)-based mouthwashes: CPC+Propolis, CPC+Malva, CPC+Eucaliptol+Juá+Romã+Propolis (Natural Honey®) and CPC (Cepacol®), against 28 Staphylococcus aureus field strains, using the agar dilution method. Decimal dilutions ranging from 1/10 to 1/655,360 were prepared and added to Mueller Hinton Agar. Strains were inoculated using Steers multipoint inoculator. The inocula were seeded onto the surface of the culture medium in Petri dishes containing different dilutions of the mouthwashes. The dishes were incubated at 37ºC for 24 h. For readings, the MID was considered as the maximum dilution of mouthwash still capable of inhibiting microbial growth. The obtained data showed that CPC+Propolis had antimicrobial activity against 27 strains at 1/320 dilution and against all 28 strains at 1/160 dilution, CPC+Malva inhibited the growth of all 28 strains at 1/320 dilution, CPC+Eucaliptol+Juá+Romã+Propolis inhibited the growth of 2 strains at 1/640 dilution and all 28 strains at 1/320 dilution, and Cepacol® showed antimicrobial activity against 3 strains at 1/320 dilution and against all 28 strains at 1/160 dilution. Data were submitted to Kruskal-Wallis test, showing that the MID of Cepacol® was lower than that determined for the other products (p<0.05). In conclusion, CPC-mouthwashes showed antimicrobial activity against S. aureus and the addition of other substances to CPC improved its antimicrobial effect.